- Center on Health Equity & Access
- Clinical
- Health Care Cost
- Health Care Delivery
- Insurance
- Policy
- Technology
- Value-Based Care
Patrick Courneya, MD, Discusses Patrick the Current Models Redesigning the Healthcare System
Patrick Courneya, MD, CHIE, health plan medical director, HealthPartners, Inc, says that his organization sees a wide variety of models in Minnesota.
Patrick Courneya, MD, CHIE, health plan medical director, HealthPartners, Inc, says that his organization sees a wide variety of models in Minnesota. The spectrum of models include single specialty primary care groups, who deliver the highest quality of care based on measures within the marketplace, to large multispecialty groups who compete effectively within the triple aim.
Dr Courneya says care delivery systems often provide services to patients in high population areas, as well as those in lower-populated areas. The challenges and solutions for each population are vastly different. “As we as a health plan work with those different organizations, we need to understand in detail about their world, their tools, their capabilities, and their aspirations as care delivery systems and as communities,” said Dr Courneya.
Empowering Teams Begins With Human Connection: Missy Hopson, PhD
April 16th 2025Missy Hopson, PhD, Ochsner Health, discussed in detail the challenges of strengthening the patient-centered workforce, the power of community reputation for encouraging health care careers, and the influence of empowered workforces on patient outcomes.
Read More
Personalized Care Key as Tirzepatide Use Expands Rapidly
April 15th 2025Using commercial insurance claims data and the US launch of tirzepatide as their dividing point, John Ostrominski, MD, Harvard Medical School, and his team studied trends in the use of both glucose-lowering and weight-lowering medications, comparing outcomes between adults with and without type 2 diabetes.
Listen
Orca-T showed lower rates of graft-vs-host disease or infection compared with allogeneic hematopoietic stem cell transplantation for myelodysplastic syndrome (MDS) or acute leukemias in the Precision-T trial, Caspian Oliai, MD, MS, UCLA Bone Marrow Transplantation Stem Cell Processing Center, said.
Read More
Navigating Sport-Related Neurospine Injuries, Surgery, and Managed Care
February 25th 2025On this episode of Managed Care Cast, we speak with Arthur L. Jenkins III, MD, FACS, CEO of Jenkins NeuroSpine, to explore the intersection of advanced surgical care for sport-related neurospine injuries and managed care systems.
Listen
